{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:17:03Z","timestamp":1792610223473,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/pr.2016.205","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T16:32:58Z","timestamp":1476117178000},"page":"265-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tuberculosis: Is the landscape changing?"],"prefix":"10.1038","volume":"81","author":[{"given":"Sutapa","family":"Khatua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby M.","family":"Geltemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Gourishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"key":"BFpr2016205_CR1","doi-asserted-by":"crossref","unstructured":"Heemskerk D, Caws M, Marais B, Farrar J. Tuberculosis in adults and children. Vol. 2. London: Springer 2015:1\u201366.","DOI":"10.1007\/978-3-319-19132-4_1"},{"key":"BFpr2016205_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","volume":"378","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis. Lancet 2011;378:57\u201372.","journal-title":"Lancet"},{"key":"BFpr2016205_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/CMR.00124-14","volume":"28","author":"M Wlodarska","year":"2015","unstructured":"Wlodarska M, Johnston JC, Gardy JL, Tang P. A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics. Clin Microbiol Rev 2015;28:523\u201339.","journal-title":"Clin Microbiol Rev"},{"key":"BFpr2016205_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tube.2015.04.003","volume":"95","author":"P Salgame","year":"2015","unstructured":"Salgame P, Geadas C, Collins L, Jones-L\u00f3pez E, Ellner JJ. Latent tuberculosis infection\u2013Revisiting and revising concepts. Tuberculosis (Edinb) 2015;95:373\u201384.","journal-title":"Tuberculosis (Edinb)"},{"key":"BFpr2016205_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1164\/rccm.200402-140OE","volume":"169","author":"JF Murray","year":"2004","unstructured":"Murray JF. A century of tuberculosis. Am J Respir Crit Care Med 2004;169:1181\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2016205_CR6","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.rmed.2006.08.006","volume":"100","author":"TM Daniel","year":"2006","unstructured":"Daniel TM. The history of tuberculosis. Respir Med 2006;100:1862\u201370.","journal-title":"Respir Med"},{"key":"BFpr2016205_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.idc.2015.05.011","volume":"29","author":"SS Chiang","year":"2015","unstructured":"Chiang SS, Swanson DS, Starke JR. New Diagnostics for Childhood Tuberculosis. Infect Dis Clin North Am 2015;29:477\u2013502.","journal-title":"Infect Dis Clin North Am"},{"key":"BFpr2016205_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al.; TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"key":"BFpr2016205_CR9","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1542\/peds.2013-2570","volume":"133","author":"J Pang","year":"2014","unstructured":"Pang J, Teeter LD, Katz DJ, et al.; Tuberculosis Epidemiologic Studies Consortium. Epidemiology of tuberculosis in young children in the United States. Pediatrics 2014;133:e494\u2013504.","journal-title":"Pediatrics"},{"key":"BFpr2016205_CR10","unstructured":"World Health Organiszation. Global tuberculosis report 2015. Geneva: WHO (\n                    http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\n                    \n                  )."},{"key":"BFpr2016205_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13052-015-0186-7","volume":"41","author":"A G\u00fcne\u015f","year":"2015","unstructured":"G\u00fcne\u015f A, Uluca \u00dc, Aktar F, et al. Clinical, radiological and laboratory findings in 185 children with tuberculous meningitis at a single centre and relationship with the stage of the disease. Ital J Pediatr 2015;41:75.","journal-title":"Ital J Pediatr"},{"key":"BFpr2016205_CR12","unstructured":"World Health Organization. Guidelines on the management of latent Tuberculosis infection. Geneva: WHO (\n                    http:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/\n                    \n                  ) 2015."},{"key":"BFpr2016205_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12879-016-1461-y","volume":"16","author":"P Laurenti","year":"2016","unstructured":"Laurenti P, Raponi M, de Waure C, Marino M, Ricciardi W, Damiani G. Performance of interferon-\u03b3 release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. BMC Infect Dis 2016;16:131.","journal-title":"BMC Infect Dis"},{"key":"BFpr2016205_CR14","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1542\/peds.2014-2983","volume":"134","author":"JR Starke","year":"2014","unstructured":"Starke JR ; Committee On Infectious Diseases. Interferon-\u03b3 release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014;134:e1763\u201373.","journal-title":"Pediatrics"},{"key":"BFpr2016205_CR15","doi-asserted-by":"publisher","first-page":"e0146098","DOI":"10.1371\/journal.pone.0146098","volume":"11","author":"IA Biraro","year":"2016","unstructured":"Biraro IA, Kimuda S, Egesa M, et al. The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda. PLoS One 2016;11:e0146098.","journal-title":"PLoS One"},{"key":"BFpr2016205_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12879-015-0814-2","volume":"15","author":"doC Giang","year":"2015","unstructured":"Giang do C, Duong TN, Ha DT, et al. Prospective evaluation of GeneXpert for the diagnosis of HIV- negative pediatric TB cases. BMC Infect Dis 2015;15:70.","journal-title":"BMC Infect Dis"},{"key":"BFpr2016205_CR17","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1016\/S2214-109X(14)70195-0","volume":"2","author":"MP Nicol","year":"2014","unstructured":"Nicol MP, Allen V, Workman L, et al. Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health 2014;2:e278\u201384.","journal-title":"Lancet Glob Health"},{"key":"BFpr2016205_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/CVI.00038-13","volume":"20","author":"N Pavan Kumar","year":"2013","unstructured":"Pavan Kumar N, Anuradha R, Andrade BB, et al. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Vaccine Immunol 2013;20:704\u201311.","journal-title":"Clin Vaccine Immunol"},{"key":"BFpr2016205_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1473-3099(14)70884-9","volume":"14","author":"D Portevin","year":"2014","unstructured":"Portevin D, Moukambi F, Clowes P, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 2014;14:931\u20138.","journal-title":"Lancet Infect Dis"},{"key":"BFpr2016205_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(16)00048-5","volume":"4","author":"TE Sweeney","year":"2016","unstructured":"Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 2016;4:213\u201324.","journal-title":"Lancet Respir Med"},{"key":"BFpr2016205_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cid\/ciu748","volume":"60","author":"R Triasih","year":"2015","unstructured":"Triasih R, Robertson CF, Duke T, Graham SM. A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases. Clin Infect Dis 2015;60:12\u20138.","journal-title":"Clin Infect Dis"},{"key":"BFpr2016205_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","volume":"169","author":"ME Villarino","year":"2015","unstructured":"Villarino ME, Scott NA, Weis SE, et al.; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr 2015;169:247\u201355.","journal-title":"JAMA Pediatr"},{"key":"BFpr2016205_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jac\/dkr173","volume":"66","author":"PE Almeida Da Silva","year":"2011","unstructured":"Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 2011;66:1417\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"BFpr2016205_CR24","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/S1473-3099(16)00070-0","volume":"16","author":"RS Wallis","year":"2016","unstructured":"Wallis RS, Maeurer M, Mwaba P, et al. Tuberculosis\u2013advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect Dis 2016;16:e34\u201346.","journal-title":"Lancet Infect Dis"},{"key":"BFpr2016205_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","volume":"123","author":"V Jarlier","year":"1994","unstructured":"Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 1994;123:11\u20138.","journal-title":"FEMS Microbiol Lett"},{"key":"BFpr2016205_CR26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","volume":"383","author":"HE Jenkins","year":"2014","unstructured":"Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014;383:1572\u20139.","journal-title":"Lancet"},{"key":"BFpr2016205_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(16)30132-3","volume":"16","author":"PJ Dodd","year":"2016","unstructured":"Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis 2016;16:1193\u2013201.","journal-title":"Lancet Infect Dis"},{"key":"BFpr2016205_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","volume":"30","author":"E De Rossi","year":"2006","unstructured":"De Rossi E, A\u00ednsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 2006;30:36\u201352.","journal-title":"FEMS Microbiol Rev"},{"issue":"Pt 2","key":"BFpr2016205_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1099\/mic.0.27629-0","volume":"151","author":"AR Flores","year":"2005","unstructured":"Flores AR, Parsons LM, Pavelka MS Jr . Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 2005;151(Pt 2):521\u201332.","journal-title":"Microbiology"},{"key":"BFpr2016205_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0923-2508(93)90023-U","volume":"144","author":"A Kochi","year":"1993","unstructured":"Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993;144:104\u201310.","journal-title":"Res Microbiol"},{"key":"BFpr2016205_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/358591a0","volume":"358","author":"Y Zhang","year":"1992","unstructured":"Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591\u20133.","journal-title":"Nature"},{"key":"BFpr2016205_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.8284673","volume":"263","author":"A Banerjee","year":"1994","unstructured":"Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227\u201330.","journal-title":"Science"},{"key":"BFpr2016205_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev.bi.65.070196.001243","volume":"65","author":"JS Blanchard","year":"1996","unstructured":"Blanchard JS. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 1996;65:215\u201339.","journal-title":"Annu Rev Biochem"},{"key":"BFpr2016205_CR34","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/AAC.00112-06","volume":"50","author":"MH Hazb\u00f3n","year":"2006","unstructured":"Hazb\u00f3n MH, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006;50:2640\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFpr2016205_CR35","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1128\/AAC.01570-07","volume":"52","author":"FS Spies","year":"2008","unstructured":"Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A. Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 2008;52:2947\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFpr2016205_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5588\/pha.15.0069","volume":"6","author":"AN Umubyeyi","year":"2016","unstructured":"Umubyeyi AN, Bonsu F, Chimzizi R, et al. The role of technical assistance in expanding access to Xpert(\u00ae) MTB\/RIF: experience in sub-Saharan Africa. Public Health Action 2016;6:32\u20134.","journal-title":"Public Health Action"},{"key":"BFpr2016205_CR37","unstructured":"WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin: Xpert MTB\/RIF system. Geneva, Switzerland: WHO. 2011."},{"key":"BFpr2016205_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S2213-2600(15)00095-8","volume":"3","author":"AK Detjen","year":"2015","unstructured":"Detjen AK, DiNardo AR, Leyden J, et al. Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med 2015;3:451\u201361.","journal-title":"Lancet Respir Med"},{"key":"BFpr2016205_CR39","doi-asserted-by":"publisher","first-page":"e0152761","DOI":"10.1371\/journal.pone.0152761","volume":"11","author":"P Eliseev","year":"2016","unstructured":"Eliseev P, Balantcev G, Nikishova E, et al. The impact of a line probe assay based diagnostic algorithm on time to treatment initiation and treatment outcomes for multidrug resistant TB patients in Arkhangelsk region, Russia. PLoS One 2016;11:e0152761.","journal-title":"PLoS One"},{"key":"BFpr2016205_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5588\/ijtld.15.0637","volume":"20","author":"T Zhang","year":"2016","unstructured":"Zhang T, Lv CF, Wang J, et al. Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB. Int J Tuberc Lung Dis 2016;20:323\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"key":"BFpr2016205_CR41","doi-asserted-by":"publisher","first-page":"e0136861","DOI":"10.1371\/journal.pone.0136861","volume":"10","author":"A Catanzaro","year":"2015","unstructured":"Catanzaro A, Rodwell TC, Catanzaro DG, et al. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLoS One 2015;10:e0136861.","journal-title":"PLoS One"},{"key":"BFpr2016205_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/2040622315582325","volume":"6","author":"SK Field","year":"2015","unstructured":"Field SK. Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? Ther Adv Chronic Dis 2015;6:170\u201384.","journal-title":"Ther Adv Chronic Dis"},{"key":"BFpr2016205_CR43","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1183\/13993003.00705-2016","volume":"48","author":"M Tadolini","year":"2016","unstructured":"Tadolini M, Garcia-Prats AJ, D\u2019Ambrosio L, et al. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges. Eur Respir J 2016;48:938\u201343.","journal-title":"Eur Respir J"},{"key":"BFpr2016205_CR44","doi-asserted-by":"publisher","first-page":"e105346","DOI":"10.1371\/journal.pone.0105346","volume":"9","author":"N Raizada","year":"2014","unstructured":"Raizada N, Sachdeva KS, Nair SA, et al. Enhancing TB case detection: experience in offering upfront Xpert MTB\/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One 2014;9:e105346.","journal-title":"PLoS One"},{"key":"BFpr2016205_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4103\/0976-9668.159988","volume":"6","author":"MK Kumar","year":"2015","unstructured":"Kumar MK, Kumar P, Singh A. Recent advances in the diagnosis and treatment of childhood tuberculosis. J Nat Sci Biol Med 2015;6:314\u201320.","journal-title":"J Nat Sci Biol Med"},{"key":"BFpr2016205_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","volume":"33","author":"SH Kaufmann","year":"2010","unstructured":"Kaufmann SH. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 2010;33:567\u201377.","journal-title":"Immunity"},{"key":"BFpr2016205_CR47","unstructured":"MDR-TB in Children: A Q&A with Partners In Health\u2019s Dr. Mercedes Becerra. (\n                    http:\/\/www.pih.org\/blog\/mdr-tb-in-children-a-qa-with-pihs-dr.-mercedes-becerra\n                    \n                  ). 2014."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016205","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:13Z","timestamp":1684616473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFpr2016205"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.205","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]},"assertion":[{"value":"18 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}